Commerce and Consumer Affairs

relative to insurance coverage for glucose monitoring.

relative to prohibiting insurance companies from conducting an audit of providers services after services have been delivered but before payment has been made to such provider.

prohibiting network exclusion for pharmacies that refuse to dispense a prescription of the PBM reimbursement that is below the pharmacy's acquisition cost.

relative to the affordability and safety of clinician administered drugs.

requiring health care providers to disclose medical services billed to the patient's insurance carrier.

relative to health care provider networks and referrals.

creating a bypass mechanism for health insurer step therapy protocols when medically necessary.

expanding the New Hampshire paid family and medical leave program.

relative to changes to health carrier contracts with providers.

relative to insurance coverage for glucose monitoring.

relative to prohibiting insurance companies from conducting an audit of providers services after services have been delivered but before payment has been made to such provider.

prohibiting network exclusion for pharmacies that refuse to dispense a prescription of the PBM reimbursement that is below the pharmacy's acquisition cost.

establishing safety and care requirements for clinician-administered drugs.

relative to children's mental health services for persons 18 years of age and younger.

relative to insurance coverage for biomarker testing.

authorizing the department of insurance to participate in a cooperative procurement group via an intergovernmental agreement for a prescription drug discount program.